046210 — HLB PanaGene Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for HLB PanaGene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	4,967	2,240	-5,538	-2,086	-3,126
Depreciation
Amortisation
Non-Cash Items	-997	244	4,951	1,482	1,315
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	713	-337	-376	-386	-518
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,012	3,361	36.1	347	-641
Capital Expenditures	-443	-362	-705	-826	-1,901
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-4,643	-4,145	-54,993	25,062	5,866
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-5,087	-4,506	-55,698	24,236	3,965
Financing Cash Flow Items	83.1	6.48	0	-12.9	-19.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6.47	-107	56,469	1,079	-9,491
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,268	-1,164	805	25,662	-6,167